Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Admune Therapeutics

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceutical and biotechnology services. The company provide medical consultancy, cytokine cancer therapies and cancer-immuno therapy.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
  • 107 Water Street
  • Danvers, MA 01923
  • United States

Admune Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Admune Therapeutics‘s full profile, request access.

Request full access to PitchBook

Admune Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Sergio Finkielsztein President & Chief Executive Officer